Table 1.
Renal outcomes per study
| Authors | Publication Year | Class IV-S | Class IV-G | Immunosuppressive Therapy | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Renal Death | No Renal Death | Follow-up (yr) | Renal Death | No Renal Death | Follow-up (yr) | |||||
| Mittal et al.8 | 2004 | 3 | 8 | 3.2 | 2 | 20 | 4.6 | Steroids; steroids and CP/MMF/AZA/MTX/plasmapheresis | ||
| Yokoyama et al.10 | 2004 | 4 | 2 | 5 | 6 | 11 | 7 | None; steroids; steroids + CP/AZA/CsA/mizoribine | ||
| Hill et al.9 | 2005 | 4 | 11 | 10 | 10 | 21 | 10 | Steroids; steroids + CP | ||
| Grootscholten et al.13 | 2008 | 0 | 15 | 6.5 | 5 | 52 | 6.3 | Steroids + AZA; steroids + CP followed by steroids + AZA | ||
| Hiramatsu et al.14 | 2008 | 1 | 13 | 5 | 4 | 37 | 5 | Steroids; steroids + CP/AZA/CsA/other | ||
| Schwartz et al.12 | 2008 | 6 | 16 | 11 | 16 | 45 | 6 | Steroids + CP; steroids + CP (+ plasmapheresis) | ||
| Kojo et al.16 | 2009 | 0 | 20 | 12.5 | 1 | 44 | 12.5 | Steroids; steroids + CP/CsA/tacrolimus/AZA/mizoribine | ||
| Yu et al.15 | 2009 | 1 | 19 | 5 | 27 | 125 | 5 | Steroids + CP followed by CP/AZA/MMF/leflunomide | ||
AZA, azathioprine; CP, cyclophosphamide; CsA, cyclosporin A; MMF, mofetil mycophenolate; MTX, methotrexate.